ChitogenX Inc.,  announced a partnership with the California Medical Innovations Institute, led by its founder Ghassan Kassab PhD. The first focus of the partnership will evaluate whether ChitogenX lyophilised chitosan matrix, combined with platelet rich plasma or other biologics can improve healing of a range of tissues germane to common surgical practice. For instance, resection of the human pancreas as is done for various tumors, is often compromised by leakage of damaging enzymes that lead to a stormy, and expensive post-operative course.

 The concept of using ChitogenX proprietary solution to address this problem would be clinically and economically meaningful.